Ha U-Syn, Cho Yong-Hyun
Department of Urology, St Vincent Hospital, The Catholic University of Korea College of Medicine, 62 Yeouido-dong, Yeongdeungpo-gu, 150-713 Seoul, Republic of Korea.
Int J Antimicrob Agents. 2006 Dec;28(6):485-90. doi: 10.1016/j.ijantimicag.2006.08.020. Epub 2006 Oct 12.
Nosocomial urinary tract infection is the most common infection acquired both in hospitals and nursing homes and is usually associated with catheterisation. These catheter-associated urinary tract infections (CAUTIs) have been reported to increase mortality and have a considerable economic impact. To date, the sole effective preventative strategy is the use of a closed drainage system and removal of the catheter as soon as possible. The underlying cause of CAUTI is the formation of a pathogenic biofilm on the surface of the indwelling urinary catheter. Currently, researchers seek to alter the catheter surface in order to inhibit biofilm formation. Many substances are being studied for their potential as biofilm-disrupting catheter coatings. Among these substances, recently developed antibiotic-coated catheters may provide promise for the control of CAUTI. More basic research at the level of pathogenesis and catheter substance is needed to design novel strategies.
医院获得性尿路感染是医院和疗养院中最常见的感染,通常与导尿有关。据报道,这些与导尿管相关的尿路感染(CAUTIs)会增加死亡率,并产生相当大的经济影响。迄今为止,唯一有效的预防策略是使用密闭引流系统并尽快拔除导尿管。CAUTI的根本原因是留置导尿管表面形成致病性生物膜。目前,研究人员试图改变导尿管表面以抑制生物膜形成。许多物质正在作为生物膜破坏型导尿管涂层的潜在材料进行研究。在这些物质中,最近开发的抗生素涂层导尿管可能为控制CAUTI带来希望。需要在发病机制和导管材料层面进行更多基础研究,以设计新的策略。